MAPT and Alzheimer disease: Elevated APH1B expression in the blood of AD patients has also been associated with deficits in the insulin-like growth factor 1 (IGF-1) signaling pathway, which is known to play a role in neuroinflammation, tau phosphorylation, and Aβ accumulation [69].